Terms: = Head and neck cancer AND MSI2, ENSG00000153944, 124540
5 results:
1. Immunohistochemical Analysis Revealed a Correlation between Musashi-2 and Cyclin-D1 Expression in Patients with Oral Squamous Cells Carcinoma.
Troiano G; Caponio VCA; Botti G; Aquino G; Losito NS; Pedicillo MC; Zhurakivska K; Arena C; Ciavarella D; Mastrangelo F; Lo Russo L; Lo Muzio L; Pannone G
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878037
[TBL] [Abstract] [Full Text] [Related]
2. Upregulation of microRNA-143-3p induces apoptosis and suppresses proliferation, invasion, and migration of papillary thyroid carcinoma cells by targeting msi2.
Wang ZL; Wang C; Liu W; Ai ZL
Exp Mol Pathol; 2020 Feb; 112():104342. PubMed ID: 31738908
[TBL] [Abstract] [Full Text] [Related]
3. Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/msi2 axis in development of thyroid cancer.
Wang ZL; Wang C; Liu W; Ai ZL
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693087
[TBL] [Abstract] [Full Text] [Related]
4. msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
Li Z; Jin H; Mao G; Wu L; Guo Q
Exp Cell Res; 2017 Dec; 361(1):170-177. PubMed ID: 29054489
[TBL] [Abstract] [Full Text] [Related]
5. Musashi-2 (msi2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
Kudinov AE; Deneka A; Nikonova AS; Beck TN; Ahn YH; Liu X; Martinez CF; Schultz FA; Reynolds S; Yang DH; Cai KQ; Yaghmour KM; Baker KA; Egleston BL; Nicolas E; Chikwem A; Andrianov G; Singh S; Borghaei H; Serebriiskii IG; Gibbons DL; Kurie JM; Golemis EA; Boumber Y
Proc Natl Acad Sci U S A; 2016 Jun; 113(25):6955-60. PubMed ID: 27274057
[TBL] [Abstract] [Full Text] [Related]
